Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Pierce Group | PIERCE | Apr 25, 2025 | 9.40 | +8.29 |
Pila Pharma | PILA | Apr 25, 2025 | 3.19 | +5.11 |
PION Group AB | PIONB | Apr 25, 2025 | 5.82 | +0.34 |
PixelFox | PIXEL | Apr 25, 2025 | 0.81 | +0.62 |
Platzer Fastigheter Holding AB (publ) | PLAZB | Apr 25, 2025 | 75.60 | +1.07 |
Plejd | PLEJD | Apr 25, 2025 | 582.00 | +1.75 |
PolarCool | POLAR | Apr 25, 2025 | 5.50 | -3.51 |
Polygiene | POLYG | Apr 25, 2025 | 9.90 | +6.45 |
Polyplank | POLY | Apr 25, 2025 | 0.04 | -3.23 |
PowerCell Sweden | PCELL | Apr 25, 2025 | 24.64 | -6.24 |
Prebona | PREBON | Apr 25, 2025 | 2.10 | +0.96 |
Precio Fishbone B | PRCOB | Apr 25, 2025 | 21.80 | -4.39 |
Precise Biometrics | PREC | Apr 25, 2025 | 4.42 | +4.39 |
Precomp Solutions B | PCOMB | Apr 25, 2025 | 0.86 | +0.58 |
Premium Snacks Nordic | SNX | Apr 25, 2025 | 26.50 | +6.85 |
Preservia Hyresfastigheter B | PHYRB | Apr 25, 2025 | 0.13 | 0.00 |
Preservium Property | PRESRV | Apr 25, 2025 | 35.00 | +30.60 |
Prevas B | PREVB | Apr 25, 2025 | 98.50 | +0.35 |
Pricer B | PRICB | Apr 25, 2025 | 5.89 | +0.68 |
Prisma Properties AB | PRISMA | Apr 25, 2025 | 24.11 | -2.01 |
Proact IT Group | PACT | Apr 25, 2025 | 117.80 | 0.00 |
ProfilGruppen B | PROFB | Apr 25, 2025 | 117.56 | +3.12 |
Profoto Holding | PRFO | Apr 25, 2025 | 26.00 | +0.78 |
Projektengagemang Sweden B | PENGB | Apr 25, 2025 | 7.34 | +2.80 |
Prolight Diagnostics | PRLD | Apr 25, 2025 | 0.40 | +3.95 |
Promimic AB | PRO | Apr 25, 2025 | 26.30 | +9.58 |
ProstaLund | PLUN | Apr 25, 2025 | 7.15 | -2.72 |
Prostatype Genomics | PROGEN | Apr 25, 2025 | 1.94 | +1.57 |
Provide IT | PROVIT | Apr 25, 2025 | 1.44 | +5.88 |
Purefun | PURE | Apr 25, 2025 | 11.80 | -7.45 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.